Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12 Suppl New
pubmed:dateCreated
2008-7-30
pubmed:abstractText
Hypertriglyceridemia is a commonly encountered problem in primary care practice. In 2002, the Third National Health and Nutrition Examination Survey reported that among adults 20 years of age and older, 30% had a triglyceride (TG) level greater than 150 mg/dL, and among people 50 years of age and older, the prevalence was 42.8%. Recent data suggest that elevated TG levels are an independent risk factor for cardiovascular disease (CVD). It is important, therefore, that clinicians identify patients with hypertriglyceridemia and initiate treatment as appropriate. In this article, we use a case study to illustrate the appropriate identification and treatment of a patient at risk. We also review the etiology of hypertriglyceridemia, its association with CVD, the recommended approach to treatment, and the efficacy and tolerability of therapeutic options.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1533-7294
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
56
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S24-31
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:18664339-Adult, pubmed-meshheading:18664339-Cardiovascular Diseases, pubmed-meshheading:18664339-Cholesterol, LDL, pubmed-meshheading:18664339-Clofibric Acid, pubmed-meshheading:18664339-Comorbidity, pubmed-meshheading:18664339-Drug Monitoring, pubmed-meshheading:18664339-Drug Therapy, Combination, pubmed-meshheading:18664339-Family Practice, pubmed-meshheading:18664339-Fatty Acids, Omega-3, pubmed-meshheading:18664339-Female, pubmed-meshheading:18664339-Health Planning Guidelines, pubmed-meshheading:18664339-Humans, pubmed-meshheading:18664339-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:18664339-Hypertriglyceridemia, pubmed-meshheading:18664339-Hypolipidemic Agents, pubmed-meshheading:18664339-Life Style, pubmed-meshheading:18664339-Niacin, pubmed-meshheading:18664339-Primary Health Care, pubmed-meshheading:18664339-Risk Factors, pubmed-meshheading:18664339-Treatment Outcome, pubmed-meshheading:18664339-Triglycerides
pubmed:year
2007
pubmed:articleTitle
Bridging the gap in treatment options for patients with hypertriglyceridemia.
pubmed:affiliation
Division of General Internal Medicine, New York University Medical School, New York, NY USA.
pubmed:publicationType
Journal Article, Review, Case Reports